Furthermore, Treg accumulation in breast cancer patients down-regulates effector T cell proliferation and pro-inflammatory factors such as IFNγ [46], thus systematically altering the immune response toward an anti-inflammatory, pro-tumorigenic phenotype facilitating tumor metastasis. The gene discussed is IFNG; the disease is breast cancer.